BlackRock, Inc. (NYSE: BLK) announced today that its iShares business
led the global industry by capturing $102.8bn in new flows in 2014, 31%
of the record-breaking $330.7bn global exchange traded fund (ETF) market
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin Data published in New England Journal of Medicine and featured at the American Society of Hematology annual meeting
Isis to host a webcast at 9:00 a.m. ET on Monday, December 8, 2014 CARLSBAD, Calif.
Isis Pharmacueticals Inc. (ISIS) said Thursday it expects to "significantly" improve on its 2014 guidance, ending the year with a pro forma net operating loss in the mid to high teens and more than $725 million cash.
Substantial reductions of up to 86% in triglycerides observed All patients achieved a triglyceride level First study to support the role of apoC-III as a key regulator of triglyceride metabolism utilizing multiple pathways
TEL AVIV, Israel , November 25, 2014 /PRNewswire/ --
ILCO announces shareholders' meeting to be held on December 31st to approve the proposed separation of its holdings, and publishes full transaction report detailing the process and proposed new structure ILCO's new strategic focus following the separation will be on its remaining public holdings, Israel Chemicals (NYSE:ICL, TASE:ICL) and Bazan (TASE:ORL), and it will refrain from investing in new companies.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.